Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic drivers of non-alcoholic fatty liver disease.

Molecular metabolism - 1 Aug 2021

Bence Kendra K, Birnbaum Morris J

Abstract excerpt

BACKGROUND: The incidence of non-alcoholic fatty liver disease (NAFLD) is rapidly increasing worldwide parallel to the global obesity epidemic. NAFLD encompasses a range of liver pathologies and most often originates from metabolically driven accumulation of fat in the liver, or non-alcoholic fatty liver (NAFL). In a subset of NAFL patients, the disease can progress to non-alcoholic steatohepatitis (NASH), which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue
Share to Disease Progression
Share to Hepatocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intestinal Mucosa

Share to Lipogenesis

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 33346069
DOI: 10.1016/j.molmet.2020.101143
PMCID: PMC8324696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic drivers of non-alcoholic fatty liver disease.PMID 33346069Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusSemantic proximity Read ↗

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read ↗

Human fatty liver disease: old questions and new insights.Semantic proximity Read ↗

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging TherapiesSemantic proximity Read ↗

Non-alcoholic fatty liver disease: molecular and cellular interplays of the lipid metabolism in a steatotic liverSemantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.Semantic proximity Read ↗

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Semantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.